These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 15964955)

  • 1. Characterization of a human reference standard for antibody to Plasmodium falciparum merozoite surface protein 1(42).
    Yoon IK; Angov E; Larson D; Heppner DG; Cummings JF; Stewart VA
    Am J Trop Med Hyg; 2005 Jun; 72(6):714-8. PubMed ID: 15964955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody responses to Plasmodium falciparum vaccine candidate antigens in three areas distinct with respect to altitude.
    Mlambo G; Mutambu SL; Mduluza T; Soko W; Mbedzi J; Chivenga J; Lanar DE; Singh S; Carucci D; Gemperli A; Kumar N
    Acta Trop; 2006 Nov; 100(1-2):70-8. PubMed ID: 17113021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and immunological characterization of E. coli expressed 42 kDa fragment of Plasmodium vivax and P. cynomolgi bastianelli merozoite surface protein-1.
    Kaushal DC; Kaushal NA; Narula A; Kumar N; Puri SK; Dutta S; Lanar DE
    Indian J Biochem Biophys; 2007 Dec; 44(6):429-36. PubMed ID: 18320841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I safety and immunogenicity trial of FMP1/AS02A, a Plasmodium falciparum MSP-1 asexual blood stage vaccine.
    Ockenhouse CF; Angov E; Kester KE; Diggs C; Soisson L; Cummings JF; Stewart AV; Palmer DR; Mahajan B; Krzych U; Tornieporth N; Delchambre M; Vanhandenhove M; Ofori-Anyinam O; Cohen J; Lyon JA; Heppner DG;
    Vaccine; 2006 Apr; 24(15):3009-17. PubMed ID: 16356603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and protective efficacy of Escherichia coli expressed Plasmodium falciparum merozoite surface protein-1(42) using human compatible adjuvants.
    Sachdeva S; Mohmmed A; Dasaradhi PV; Crabb BS; Katyal A; Malhotra P; Chauhan VS
    Vaccine; 2006 Mar; 24(12):2007-16. PubMed ID: 16377036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The establishment of a WHO Reference Reagent for anti-malaria (Plasmodium falciparum) human serum.
    Bryan D; Silva N; Rigsby P; Dougall T; Corran P; Bowyer PW; Ho MM;
    Malar J; 2017 Aug; 16(1):314. PubMed ID: 28779755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variant-specific antibodies to merozoite surface protein 2 and clinical expression of Plasmodium falciparum malaria in rural Amazonians.
    Scopel KK; da Silva-Nunes M; Malafronte RS; Braga EM; Ferreira MU
    Am J Trop Med Hyg; 2007 Jun; 76(6):1084-91. PubMed ID: 17556615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection.
    John CC; Moormann AM; Pregibon DC; Sumba PO; McHugh MM; Narum DL; Lanar DE; Schluchter MD; Kazura JW
    Am J Trop Med Hyg; 2005 Jul; 73(1):222-8. PubMed ID: 16014863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya.
    Stoute JA; Gombe J; Withers MR; Siangla J; McKinney D; Onyango M; Cummings JF; Milman J; Tucker K; Soisson L; Stewart VA; Lyon JA; Angov E; Leach A; Cohen J; Kester KE; Ockenhouse CF; Holland CA; Diggs CL; Wittes J; Heppner DG;
    Vaccine; 2007 Jan; 25(1):176-84. PubMed ID: 16388879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fusion protein Dot-ELISA for the detection of Plasmodium falciparum antibodies].
    Liu KY; Kidson C
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1991; 9(1):43-5. PubMed ID: 2065453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG subclasses pattern and high-avidity antibody to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in an unstable hypoendemic region in Iran.
    Mehrizi AA; Zakeri S; Salmanian AH; Sanati MH; Djadid ND
    Acta Trop; 2009 Oct; 112(1):1-7. PubMed ID: 19481997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometric identification of an HLA-A*0201 epitope from Plasmodium falciparum MSP-1.
    Carralot JP; Lemmel C; Stevanovic S; Pascolo S
    Int Immunol; 2008 Nov; 20(11):1451-6. PubMed ID: 18794202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan.
    Iriemenam NC; Khirelsied AH; Nasr A; ElGhazali G; Giha HA; Elhassan A-Elgadir TM; Agab-Aldour AA; Montgomery SM; Anders RF; Theisen M; Troye-Blomberg M; Elbashir MI; Berzins K
    Vaccine; 2009 Jan; 27(1):62-71. PubMed ID: 18977268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG antibody profile to c-terminal region of Plasmodium vivax merozoite surface protein-1 in Thai individuals exposed to malaria.
    Pitabut N; Panichakorn J; Mahakunkijcharoen Y; Hirunpetcharat C; Looareesuwan S; Khusmith S
    Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):1-7. PubMed ID: 17539238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicentric evaluation of the DiaMed enzyme-linked immunosorbent assay malaria antibody test for screening of blood donors for malaria.
    Elghouzzi MH; Senegas A; Steinmetz T; Guntz P; Barlet V; Assal A; Gallian P; Volle P; Chuteau C; Beolet M; Berrebi S; Filisetti D; Doderer C; Abdelrahman T; Candolfi E
    Vox Sang; 2008 Jan; 94(1):33-40. PubMed ID: 18021184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence diversity and evolutionary dynamics of the dimorphic antigen merozoite surface protein-6 and other Msp genes of Plasmodium falciparum.
    Roy SW; Weedall GD; da Silva RL; Polley SD; Ferreira MU
    Gene; 2009 Aug; 443(1-2):12-21. PubMed ID: 19463923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium falciparum: worldwide sequence diversity and evolution of the malaria vaccine candidate merozoite surface protein-2 (MSP-2).
    Ferreira MU; Hartl DL
    Exp Parasitol; 2007 Jan; 115(1):32-40. PubMed ID: 16797008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, solution structure and immune recognition of an epidermal growth factor-like domain from Plasmodium falciparum merozoite surface protein-1.
    James S; Moehle K; Renard A; Mueller MS; Vogel D; Zurbriggen R; Pluschke G; Robinson JA
    Chembiochem; 2006 Dec; 7(12):1943-50. PubMed ID: 17068840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High titers of IgG antibodies against Plasmodium falciparum serine repeat antigen 5 (SERA5) are associated with protection against severe malaria in Ugandan children.
    Okech B; Mujuzi G; Ogwal A; Shirai H; Horii T; Egwang TG
    Am J Trop Med Hyg; 2006 Feb; 74(2):191-7. PubMed ID: 16474069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
    Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
    Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.